Pharmacies & Drug Stores in Canada
Over the five years to 2019, the Pharmacies and Drug Stores industry in Canada has benefited from the fact that pharmaceuticals currently comprise the second-largest health expenditure category in Canada. Although increasing pharmaceutical prices have bolstered industry revenue over the five years to 2019, many provincial drug programs have also restricted prescription prices to cut healthcare costs to consumers, hurting industry operators in the process. Many pharmacies and drug stores have been able to generate strong revenue streams from generic drugs with increasing volumes due to their increasing affordability. After several patent cliffs during which operators grappled with the patent loss of many brand-name drugs and the subsequent inundation of the market with generic substitutes, the high volume of lower-margin generic drugs buoyed industry revenue. As research and development expenditure rises over the five years to 2024, more pharmaceuticals will come off pharmaceutical manufacturers' drug pipelines, thus benefiting the industry.
This industry retails a range of prescription and over-the-counter medications, health and beauty items, toiletries and consumable goods directly to consumers on a walk-in basis. Industry operators may also provide basic health and photo-processing services. The industry includes retail stores with a pharmacy, but excludes mail order and online retailers, hospitals and clinics.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook